Azathioprine Withdrawn Phase 2 Trials for Granulomatous and Lymphocytic Interstitial Lung Disease Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02789397Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency